MetaCap

BioCryst Pharmaceuticals Statistics

NASDAQ: BCRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

7.22-0.10 (-1.37%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BioCryst Pharmaceuticals by the numbers

BioCryst Pharmaceuticals has a market capitalization of $1.86 billion based on 257.30M shares outstanding. With trailing EPS of $-1.28, BioCryst Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.7% below its 50-day average and 18.2% below its 200-day average.

Average daily trading volume is 4.97M shares, or about $35.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

BCRX valuation vs. peer median

BCRX compared with the median of 8 peer companies
MetricBCRXPeer medianDifference
Market cap$1.86B$1.72B+8%
Avg. volume4.97M1.59M+213%

Peer median across 8 companies: COAG, REPL, LYCA, MAZE, BEAM, VIR, RXRX, ALVO.

Valuation

Price / sales (latest FY)
2.12
EPS (TTM)
$-1.28

Price and trading

Previous close
7.32
Open
7.26
Day range
7.15 – 7.39
52-week range
6.23 – 11.22
52-week change
+3.59%
Beta
—
Volume
3.85M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.86B
Forward Pe
8.44
Eps
-1.28
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
11.22
Week52 Low
6.23
Avg Volume
4.97M
Shares Outstanding
257.30M
Ma50
8.08
Ma200
8.82
Earnings Date
Nov 4, 2026
Pct From52w High
-35.65%
Pct From52w Low
15.89%

Related